BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28946136)

  • 1. The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis.
    Zhao J; Shi X; Wang T; Ying C; He S; Chen Y
    Cell Physiol Biochem; 2017; 43(2):697-704. PubMed ID: 28946136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of IGF-1R in lung cancer: A PRISMA-compliant meta-analysis.
    Xu J; Bie F; Wang Y; Chen X; Yan T; Du J
    Medicine (Baltimore); 2019 May; 98(19):e15467. PubMed ID: 31083179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
    Kim JS; Kim ES; Liu D; Lee JJ; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee E; Lee HY
    Oncotarget; 2015 Jun; 6(18):16746-56. PubMed ID: 25944691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
    Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
    Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.
    Kim JS; Kim ES; Liu D; Lee JJ; Solis L; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee HY
    Clin Lung Cancer; 2014 May; 15(3):213-21. PubMed ID: 24485233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.
    Kim JS; Kim ES; Liu D; Lee JJ; Solis L; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee HY
    Cancer; 2012 May; 118(9):2454-65. PubMed ID: 21952750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
    Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
    Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.
    Agulló-Ortuño MT; Díaz-García CV; Agudo-López A; Pérez C; Cortijo A; Paz-Ares L; López-Ríos F; Pozo F; de Castro J; Cortés-Funes H; López Martín JA
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):43-53. PubMed ID: 25081930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
    Zhao S; Qiu Z; He J; Li L; Li W
    Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and insulin-like growth factor-1 synergistically promote the progression of NSCLC.
    Tang H; Bai Y; Pan G; Wang X; Wei Y; Yang Z; Zhao J
    Autoimmunity; 2018 Dec; 51(8):399-407. PubMed ID: 30604632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of CD44 expression in non-small cell lung cancer: a systematic review.
    Luo Z; Wu RR; Lv L; Li P; Zhang LY; Hao QL; Li W
    Int J Clin Exp Pathol; 2014; 7(7):3632-46. PubMed ID: 25120740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
    Liao DW; Wang L; Zhang XG; Liu MQ
    Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
    Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
    J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p16 in non-small cell lung cancer and its prognostic significance: a meta-analysis of published literatures.
    Tong J; Sun X; Cheng H; Zhao D; Ma J; Zhen Q; Cao Y; Zhu H; Bai J
    Lung Cancer; 2011 Nov; 74(2):155-63. PubMed ID: 21621871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
    Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
    World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
    Min SH; Zheng QQ
    Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis.
    Wu H; Qi XW; Yan GN; Zhang QB; Xu C; Bian XW
    PLoS One; 2014; 9(6):e100168. PubMed ID: 24940615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.